Use of Oral JAK Inhibitors and a TYK2 Inhibitor in the Treatment of Psoriasis-Eczema Overlap (PsEma): A Retrospective Study - PubMed
6 hours ago
- #JAK inhibitors
- #Atopic Dermatitis
- #Psoriasis-Eczema Overlap
- Retrospective study on oral JAK inhibitors and TYK2 inhibitor in PsEma.
- Treatment targets psoriasis-eczema overlap condition.
- Key themes: JAK inhibitors, TYK2 inhibitor, atopic dermatitis, psoriasis.
- Reference ID: PMID: 41964149, DOI: 10.1111/ijd.70393.